Genetic variation of CYP3A5 influences paclitaxel/carboplatin-induced toxicity in Chinese epithelial ovarian cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic variation of CYP3A5 influences paclitaxel/carboplatin-induced toxicity in Chinese epithelial ovarian cancer patients

Published:2015-10-26 Issue:3 Volume:56 Page:349-354
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Hu Lei¹²,Lv Qiao-Li¹²,Guo Ying¹²,Cheng Lin¹²,Wu Na-Yiyuan¹²,Qin Chong-Zhen³,Zhou Hong-Hao¹²

Affiliation:

1. Department of Clinical Pharmacology, Xiangya Hospital; Central South University; Changsha People's Republic of China

2. Institute of Clinical Pharmacology; Central South University; Hunan Key Laboratory of Pharmacogenetics; Changsha People's Republic of China

3. Department of Pharmacy; the First Affiliated Hospital of Zhengzhou University; Zhengzhou China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.587/fullpdf

Reference40 articles.

1. Cancer of the ovary;Cannistra;N Engl J Med,1993

2. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms;Socinski;Clin Cancer Res,2004

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003

4. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

5. Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II study;Guastalla;Ann Oncol,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based chemotherapy: trends in organic nanodelivery systems;Nanoscale;2024

2. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention;Biomedicines;2023-10-26

3. CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study;Frontiers in Pharmacology;2023-07-04

4. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity;Methods in Molecular Biology;2022

5. Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies;Basic & Clinical Pharmacology & Toxicology;2021-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3